Have a personal or library account? Click to login
Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions Cover

Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions

By: J. Strindberg,  J. Lundahl and  G. Ajne  
Paid access
|Dec 2019

References

  1. Nance S, Nelson J, Horenstein J, Arndt P, Platt L, Garratty G. Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989;92:89–92.10.1093/ajcp/92.1.89
  2. Smith G, Knott P, Rissik J, de la Fuente J, Win N. Anti-U and haemolytic disease of the fetus and newborn. Br J Obstet Gynaecol 1998;105:1318–21.10.1111/j.1471-0528.1998.tb10013.x
  3. Austin TKL, Finkelstein J, Okada DM, Myhre B, Sturgeon P. Letter: hemolytic disease of the newborn infant due to anti-U. J Pediatr 1976;89:330–1.10.1016/S0022-3476(76)80504-5
  4. Dopp SL, Isham BE. Anti-U and hemolytic disease of the newborn. Transfusion 1983;23:273–4.10.1046/j.1537-2995.1983.23383224919.x6679391
DOI: https://doi.org/10.21307/immunohematology-2019-124 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 51 - 54
Published on: Dec 1, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 J. Strindberg, J. Lundahl, G. Ajne, published by American National Red Cross
This work is licensed under the Creative Commons License.